0001493152-20-022769.txt : 20201201 0001493152-20-022769.hdr.sgml : 20201201 20201201170031 ACCESSION NUMBER: 0001493152-20-022769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201129 FILED AS OF DATE: 20201201 DATE AS OF CHANGE: 20201201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drexler Ryan Charles CENTRAL INDEX KEY: 0001648033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53166 FILM NUMBER: 201361485 MAIL ADDRESS: STREET 1: 525 CHALETTE DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MusclePharm Corp CENTRAL INDEX KEY: 0001415684 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770664193 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: (800) 210-7369 MAIL ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 FORMER COMPANY: FORMER CONFORMED NAME: Tone in Twenty DATE OF NAME CHANGE: 20071018 4 1 ownership.xml X0306 4 2020-11-29 0 0001415684 MusclePharm Corp MSLP 0001648033 Drexler Ryan Charles C/O MUSCLEPHARM CORPORATION 4500 PARK GRANADA, SUITE 202 CALABASAS CA 91302 1 1 1 0 CEO and President Convertible Promissory Note 0.23 2020-11-29 4 J 0 2871967 0.23 A 2021-07-01 Common Stock 12486813 2871967 D On November 29, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,871,967 with the Company (the "November 2020 Convertible Note"). Mr. Drexler may elect to convert all or any portion of the convertible amount into shares of the Company's common stock at any time for $0.23 per share at any time. Both the principal and any accrued but unpaid interest under the November 2020 Convertible Note will become due and payable on July 1, 2021, unless earlier converted or repaid. /s/ Ryan Charles Drexler 2020-12-01